Abbreviated MRI Screening in Turkish Women Aged 40-69 With Dense Breasts: A Prospective Feasibility Study

Author:

Yirgin Inci Kizildag1,Cabioglu Neslihan1,Dursun Memduh1,Can Omur2,Sener Aziz,Vatandas Gulcin2,Aykuter Gonul2,Yilmaz Ravza1,Ozaydin Ayse Nilufer3,Gurdal Sibel Ozkan4,Ozcinar Beyza1,Akyurt Nuran5,Ozmen Vahit1,Kayhan Arda,Aribal Erkin6

Affiliation:

1. Istanbul University

2. Bahçeşehir Breast Cancer Screening Center

3. Marmara University School of Medicine

4. Namik Kemal University

5. Techniques Marmara University Istanbul

6. Acibadem M.A.A University school of medicine

Abstract

Abstract

Background Survival time and quality of life increase with the early diagnosis of breast cancer. We aim to investigate the feasibility of abbreviated protocol (AP) breast magnetic resonance imaging (MRI) screening in women with dense breasts in a screening program in a middle-income country. Methods The study included 649 women selected randomly from 1285 women with type C and D breasts in a screening program, of which 238 underwent an abbreviated breast MRI screening (AP-MRI). The AP-MRI consisted of dynamic series during the first and second post-contrast phases, in addition to axial T1W and axial T2W-fat sat (TRIM) sequences. The reference standard for the study was based on pathology results obtained from biopsies and normal screening mammography results within two years. Results MRI scans of 201 women (84.4%) displayed normal or benign findings (BIRADS-1 and 2). An additional 25 women (10.5%) were recommended for MRI or ultrasound (USG) follow-up (BI-RADS-3) and did not show any progression in the two-year follow-up. The remaining 12 women (5%) were recommended a biopsy (BIRADS-4), of which five were reclassified as BIRADS-3 after a second-look ultrasound. Subsequently, a biopsy of the remaining seven patients. did not reveal any malignancies. They all had a negative two-year follow-up. The main challenges encountered were scheduling AP-MRI screening and compliance of women. Conclusion This study highlights that supplemental AP-MRI screening may not offer universal benefits for all women with dense breasts. The use of AP breast MRI could potentially lead to overdiagnosis and unnecessary biopsies, primarily due to false positive findings on MRI scans.

Publisher

Springer Science and Business Media LLC

Reference53 articles.

1. - Data source. Globocan 2020 Graph production: Global Cancer Observatory (http://gco.iarc.fr).

2. Increasing incidence of and declining mortality from breast carcinoma;- Garne JP;Cancer,1997

3. Swedish two-county trial: Impact of mammographic screening on breast cancer mortality during 3 decades;-Tabar L;Radiology,2011

4. Mammographic screening and breast cancer mortality: A case-control study and meta-analysis;Nickson C;Cancer Epidemiol Biomarkers Prev,2012

5. The impact of mammographic screening on breast cancer mortality in Europe: A review of observational studies;Broeders M;J Med ¨ Screen,2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3